Medium-Hard Algorithm Focus
Backend engineers encounter more complex data structure problems, especially around trees, graphs, and concurrent programming patterns.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Backend engineers face unique challenges around distributed systems, API design, and data consistency.. Explore key insights and preparation tips to help you excel in your interview process.
Backend engineers encounter more complex data structure problems, especially around trees, graphs, and concurrent programming patterns.
System design questions focus heavily on API design, database scaling, and service communication patterns.
API Design
RESTful services and GraphQL patterns
Database Scaling
Sharding, replication, and consistency
Microservices
Service mesh and inter-service communication
Different companies emphasize different backend specializations based on their technical challenges.
Netflix
Streaming infrastructure and content delivery networks
Stripe
Payment processing reliability and financial data consistency
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers backend engineers approximately 60% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.3M+ in the Bay Area. Your tech salary stretches significantly further, enabling homeownership and higher savings rates while maintaining quality of life in a historic East Coast city.
Baltimore's backend engineering market is less saturated than major tech hubs, offering better positioning for career advancement and competitive offers from growing companies.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States